Literature DB >> 26868139

Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.

Hyo Sang Lee1, Jungsu S Oh1, Young Soo Park2, Se Jin Jang2, Ik Soo Choi3, Jin-Sook Ryu4.   

Abstract

OBJECTIVE: We aimed to explore the ability of textural heterogeneity indices determined by (18)F-FDG PET/CT for grading the malignancy of thymic epithelial tumors (TETs).
METHODS: We retrospectively enrolled 47 patients with pathologically proven TETs who underwent pre-treatment (18)F-FDG PET/CT. TETs were classified by pathological results into three subgroups with increasing grades of malignancy: low-risk thymoma (LRT; WHO classification A, AB and B1), high-risk thymoma (B2 and B3), and thymic carcinoma (TC). Using (18)F-FDG PET/CT, we obtained conventional imaging indices including SUVmax and 20 intratumoral heterogeneity indices: i.e., four local-scale indices derived from the neighborhood gray-tone difference matrix (NGTDM), eight regional-scale indices from the gray-level run-length matrix (GLRLM), and eight regional-scale indices from the gray-level size zone matrix (GLSZM). Area under the receiver operating characteristic curve (AUC) was used to demonstrate the abilities of the imaging indices for differentiating subgroups. Multivariable logistic regression analysis was performed to show the independent significance of the textural indices. Combined criteria using optimal cutoff values of the SUVmax and a best-performing heterogeneity index were applied to investigate whether they improved differentiation between the subgroups.
RESULTS: Most of the GLRLM and GLSZM indices and the SUVmax showed good or fair discrimination (AUC >0.7) with best performance for some of the GLRLM indices and the SUVmax, whereas the NGTDM indices showed relatively inferior performance. The discriminative ability of some of the GLSZM indices was independent from that of SUVmax in multivariate analysis. Combined use of the SUVmax and a GLSZM index improved positive predictive values for LRT and TC.
CONCLUSIONS: Texture analysis of (18)F-FDG PET/CT scans has the potential to differentiate between TET tumor grades; regional-scale indices from GLRLM and GLSZM perform better than local-scale indices from the NGTDM. The SUVmax and heterogeneity indices may have complementary value in differentiating TET subgroups.

Entities:  

Keywords:  18F-FDG PET/CT; Intratumoral heterogeneity; Texture analysis; Thymic epithelial tumor; Thymoma

Mesh:

Substances:

Year:  2016        PMID: 26868139     DOI: 10.1007/s12149-016-1062-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  16 in total

1.  Texture analysis of 18F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Tetsuya Shinaji; Masayuki Nakajo; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

2.  A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.

Authors:  Masatoyo Nakajo; Yoriko Kajiya; Atsushi Tani; Megumi Jinguji; Masayuki Nakajo; Masaki Kitazono; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-03       Impact factor: 9.236

3.  A combined postoperative nomogram for survival prediction in clear cell renal carcinoma.

Authors:  Ying Ming; Xinyi Chen; Jingxu Xu; Haiyu Zhan; Jie Zhang; Teng Ma; Chencui Huang; Zhiling Liu; Zhaoqin Huang
Journal:  Abdom Radiol (NY)       Date:  2021-10-13

Review 4.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

5.  [Computed tomography-based radiomics for differential of retroperitoneal neuroblastoma and ganglioneuroblastoma in children].

Authors:  H Wang; X Chen; H Liu; C Yu; L He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-10-20

6.  Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Yoshiaki Nakabeppu; Masayuki Nakajo; Ryutarou Higashi; Yoshihiko Fukukura; Ken Sasaki; Yasuto Uchikado; Shoji Natsugoe; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-10       Impact factor: 9.236

7.  Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis.

Authors:  Sangwon Han; Sungmin Woo; Yong-Il Kim; Dok Hyun Yoon; Jin-Sook Ryu
Journal:  Eur Radiol       Date:  2020-08-18       Impact factor: 5.315

8.  Predicting pathological subtypes and stages of thymic epithelial tumors using DWI: value of combining ADC and texture parameters.

Authors:  Bo Li; Yong-Kang Xin; Gang Xiao; Gang-Feng Li; Shi-Jun Duan; Yu Han; Xiu-Long Feng; Wei-Qiang Yan; Wei-Cheng Rong; Shu-Mei Wang; Yu-Chuan Hu; Guang-Bin Cui
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

9.  CT Radiomic Features for Predicting Resectability and TNM Staging in Thymic Epithelial Tumors.

Authors:  Jose Arimateia Batista Araujo-Filho; Maria Mayoral; Junting Zheng; Kay See Tan; Peter Gibbs; Annemarie Fernandes Shepherd; Andreas Rimner; Charles B Simone; Gregory Riely; James Huang; Michelle S Ginsberg
Journal:  Ann Thorac Surg       Date:  2021-04-09       Impact factor: 5.102

10.  Exploratory Analysis of 18F-3'-deoxy-3'-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.

Authors:  Lorenzo Fantini; Maria Luisa Belli; Irene Azzali; Emiliano Loi; Andrea Bettinelli; Giacomo Feliciani; Emilio Mezzenga; Anna Fedeli; Silvia Asioli; Giovanni Paganelli; Anna Sarnelli; Federica Matteucci
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.